One prominent drug treating this disease targets the dihydrofolate reductas
One prominent drug treating this disease targets the dihydrofolate reductase of this disease's bacterial cause. That drug is isoniazid, which along with rifampicin, is part of the four-drug RIPE regimen used to treat it. The lipid-rich cell wall of its bacterial cause is composed primarily of mycolic acid, which prevents diagnosis of this disease by Gram staining. Instead the Ziehl Neelsen stain is used to classify it, and clinically, either its latent or active form can be detected in the PPD skin test. For 10 points, name this airborne disease whose symptoms can include coughing up blood, often abbreviated TB.
One prominent drug treating this disease targets the dihydrofolate reductase of this disease's bacterial cause.
{tuberculosis} [accept {TB} before mentioned]